RenaissanceRe Holdings Ltd. removed from BofA Global Research’s US 1 list
RNR•BofA Global Research removed RenaissanceRe Holdings Ltd. from its US 1 list.
Related News
Guardant Health raises target price to $210 from $195
GH•
CoinShares board approves $40 million share repurchase program
CSHR•
Gerdau reports Q3 2026 adjusted EBITDA of R$ 3.8 billion
GGB•
Harvard Bioscience publishes update to financial calendar
HBIO•
Wave Life Sciences Q3 net loss widens 15% to $61.91 million; revenue rises 73% to $13.16 million
WVE•